Statement of the Anti-Red Tape Authority on FDA’s Granting of Compassionate Special Permit to a Hospital for use of Ivermectin on Covid-19 patients

The Anti-Red Tape Authority (ARTA) welcomes the move of the Food and Drug Administration (FDA) for granting the application of a hospital for a Compassionate Special Permit to use Ivermectin on humans with COVID-19. With this, ARTA urges FDA to continue processing applications from other medical institutions seeking the same permit expeditiously while key agencies.. read more

ARTA to FDA: Expedite application process for Ivermectin

29 March 2021 – The Anti-Red Tape Authority (ARTA) is urging the Food and Drug Administration (FDA) to expedite its processing of applications for the use of Ivermectin, an anti-parasitic drug undergoing trials for the possible treatment of COVID-19 symptoms. This, after the FDA announced earlier today that doctors and hospitals may now apply for.. read more